An Open-Label Clinical Study Involving 10 Participants to Evaluate the Therapeutic Effect of Virechana Followed by Yastimadhu Rasayana on Neurotransmitters and Skin Condition Considering the Prevalence of Psycho dermatological Manifestations.

An Open-Label Clinical Study to Evaluate the Therapeutic Effect of Virechana Followed by Yastimadhu Rasayana on Neurotransmitters in Psycho dermatological Skin Manifestations. - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/092175

Enrollment

Registered

2025-08-01

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F459- Somatoform disorder, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients fulfilling diagnostic criteria 2.Patients with age group between 18-60 years 3.Patient willing to sign informed consent. 4.Patient fit for Virechana karma.

Exclusion criteria

Exclusion criteria: 1.Patients with any other systemic illness interfering with the present treatment. 2.Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
To evaluate the therapeutic effect of Virechana followed by Yastimadhu Rasayana on 1.Level of Neurotransmitter 2.Hamilton rating scale. 3.Specific skin assessment scale. Timepoint: 0th day 17th (+/-5) day 47th (+/-4) day	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr Dhaneshwari H A

Sri Dharmasthala Manjunatheshwara College of Ayurveda

drdhaneshwarisdm@gmail.com9900554202

Outcome results